Improving HIV testing and treatment for commercial minibus drivers
Innovative Tools to Expand HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs)
This study is all about making it easier for commercial minibus drivers in Nigeria to get tested and treated for HIV, using private self-testing and long-lasting treatments, so they can stay healthy while managing their busy lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11009232 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to HIV testing and treatment for commercial minibus drivers, a group at high risk for HIV due to their mobile lifestyle. The project aims to implement innovative strategies such as HIV self-testing, which allows drivers to test privately, and long-acting injectables for HIV treatment and prevention. By addressing the barriers these drivers face in accessing healthcare, the research seeks to improve their health outcomes and adherence to treatment. The study will leverage previous successful interventions tailored for youth to create a specific program for this population in Nigeria.
Who could benefit from this research
Good fit: Ideal candidates for this research are commercial minibus drivers who are at risk for HIV or are living with HIV.
Not a fit: Patients who are not involved in the commercial driving profession or those who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HIV testing rates and improve treatment adherence among commercial minibus drivers.
How similar studies have performed: Previous research has shown success with similar interventions aimed at increasing HIV testing and treatment adherence among high-risk populations.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Conserve, Donaldson — George Washington University
- Study coordinator: Conserve, Donaldson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.